Literature DB >> 15147245

Tools for diagnosing migraine and measuring its severity.

Richard B Lipton1, Marcelo E Bigal, Joan C Amatniek, Walter F Stewart.   

Abstract

Migraine remains substantially underdiagnosed and undertreated in the United States. Tools to screen for migraine and to measure headache-related disability can help address barriers to effective diagnosis and treatment. In this article, public health criteria for screening programs for any medical condition are first reviewed. Modifications of these criteria for migraine and other chronic/episodic disorders are then proposed. Migraine is assessed to determine how well it meets criteria for screening and the steps that are necessary before firm public policy recommendations for screening for migraine are possible.

Entities:  

Mesh：

Year:  2004        PMID： 15147245     DOI： 10.1111/j.1526-4610.2004.04089.x

Source DB:  PubMed          Journal:  Headache        ISSN： 0017-8748            Impact factor:   5.887


  12 in total

1.  A randomized trial of a web-based intervention to improve migraine self-management and coping.

Authors:  Jonas Bromberg; Mollie E Wood; Ryan A Black; Daniel A Surette; Kevin L Zacharoff; Emil J Chiauzzi
Journal:  Headache       Date:  2012-02       Impact factor: 5.887

Review 2.  Why HURT? A review of clinical instruments for headache management.

Authors:  Dawn C Buse; C Mark Sollars; Timothy J Steiner; Rigmor H Jensen; Mohammed A Al Jumah; Richard B Lipton
Journal:  Curr Pain Headache Rep       Date:  2012-06

3.  In-office discussions of migraine: results from the American Migraine Communication Study.

Authors:  Richard B Lipton; Steven R Hahn; Roger K Cady; Jan Lewis Brandes; Suzanne E Simons; Philip A Bain; Meaghan R Nelson
Journal:  J Gen Intern Med       Date:  2008-05-06       Impact factor: 5.128

4.  Long-term effects of a sensitisation campaign on migraine: the Casilino study.

Authors:  B Petolicchio; L Di Clemente; M Altieri; E Vicenzini; G L Lenzi; Vittorio Di Piero
Journal:  J Headache Pain       Date:  2010-04       Impact factor: 7.277

5.  The pharmacological management of migraine, part 1: overview and abortive therapy.

Authors:  George Demaagd
Journal:  P T       Date:  2008-07

6.  Impact of headache on young people in a school population.

Authors:  David Kernick; Deborah Reinhold; John L Campbell
Journal:  Br J Gen Pract       Date:  2009-09       Impact factor: 5.386

7.  Comparison of validity and reliability of the Migraine disability assessment (MIDAS) versus headache impact test (HIT) in an Iranian population.

Authors:  Abbas Ghorbani; Ahmad Chitsaz
Journal:  Iran J Neurol       Date:  2011

Review 8.  Optimal Dosing of Lasmiditan in the Management of Acute Migraine Attack: A Systematic Review and Meta-analysis.

Authors:  Roopa Satyanarayan Basutkar; Chris Elizabeth Vinod; Shruthi Jaya Saju; Bhavya Chebrolu; Sivasankaran Ponnusankar
Journal:  Ann Indian Acad Neurol       Date:  2021-04-10       Impact factor: 1.383

9.  The effects of a sensitisation campaign on unrecognised migraine: the Casilino study.

Authors:  Vittorio Di Piero; Marta Altieri; Giuseppe Conserva; Barbara Petolicchio; Laura Di Clemente; Jayasena Hettiarachchi
Journal:  J Headache Pain       Date:  2007-09-24       Impact factor: 7.277

10.  Maternal personality profile of children affected by migraine.

Authors:  Maria Esposito; Michele Roccella; Beatrice Gallai; Lucia Parisi; Serena Marianna Lavano; Rosa Marotta; Marco Carotenuto
Journal:  Neuropsychiatr Dis Treat       Date:  2013-09-11       Impact factor: 2.570
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.